Literature DB >> 15983200

Autocrine action of adiponectin on human fat cells prevents the release of insulin resistance-inducing factors.

Daniela Dietze-Schroeder1, Henrike Sell, Mathias Uhlig, Marlis Koenen, Jürgen Eckel.   

Abstract

The adipocyte hormone adiponectin is negatively correlated with obesity and insulin resistance and may exert an important antidiabetes function. In this study, primary human skeletal muscle cells were cocultured with human fat cells or incubated with adipocyte-conditioned medium in the presence or absence of the globular domain of adiponectin (gAcrp30) to analyze its capacity to restore normal insulin signaling in the muscle cells. Human skeletal muscle cells cocultured with adipocytes or treated with adipocyte-conditioned medium showed an impaired Akt and glycogen synthase kinase 3 serine phosphorylation in response to insulin. Furthermore, insulin-stimulated GLUT4 translocation was reduced by adipocyte-conditioned medium. Impaired insulin signaling was normalized upon addition of gAcrp30 to the coculture. Further, adipocyte-conditioned medium generated in the presence of gAcrp30 was unable to perturb insulin-stimulated Akt phosphorylation. Concomitant addition of gAcrp30 and adipocyte-conditioned medium to the myocytes failed to restore normal insulin action. Protein array analysis of adipocyte-conditioned medium indicated that the secretion of at least eight different cytokines was diminished in response to gAcrp30. We therefore suggest that adiponectin operates as a key regulator of adipocyte secretory function. This autocrine action may prevent the induction of skeletal muscle insulin resistance and may partly explain the antidiabetes action of this hormone.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15983200     DOI: 10.2337/diabetes.54.7.2003

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  34 in total

1.  Contractile activity of human skeletal muscle cells prevents insulin resistance by inhibiting pro-inflammatory signalling pathways.

Authors:  S Lambernd; A Taube; A Schober; B Platzbecker; S W Görgens; R Schlich; K Jeruschke; J Weiss; K Eckardt; J Eckel
Journal:  Diabetologia       Date:  2012-01-27       Impact factor: 10.122

2.  Adiponectin in human pregnancy: implications for regulation of glucose and lipid metabolism.

Authors:  P M Catalano; M Hoegh; J Minium; L Huston-Presley; S Bernard; S Kalhan; S Hauguel-De Mouzon
Journal:  Diabetologia       Date:  2006-05-11       Impact factor: 10.122

3.  Regulation of retinol binding protein 4 production in primary human adipocytes by adiponectin, troglitazone and TNF-alpha.

Authors:  H Sell; J Eckel
Journal:  Diabetologia       Date:  2007-07-28       Impact factor: 10.122

4.  Identification and validation of novel adipokines released from primary human adipocytes.

Authors:  Stefan Lehr; Sonja Hartwig; Daniela Lamers; Susanne Famulla; Stefan Müller; Franz-Georg Hanisch; Claude Cuvelier; Johannes Ruige; Kristin Eckardt; D Margriet Ouwens; Henrike Sell; Juergen Eckel
Journal:  Mol Cell Proteomics       Date:  2011-09-26       Impact factor: 5.911

Review 5.  [Adipose tissue--an endocrine organ].

Authors:  M Blüher
Journal:  Internist (Berl)       Date:  2014-06       Impact factor: 0.743

Review 6.  Adiponectin: mechanistic insights and clinical implications.

Authors:  A T Turer; P E Scherer
Journal:  Diabetologia       Date:  2012-06-12       Impact factor: 10.122

7.  Adiponectin deficiency: role in chronic inflammation induced colon cancer.

Authors:  Arpit Saxena; Alexander Chumanevich; Emma Fletcher; Bianca Larsen; Kirby Lattwein; Kamaljeet Kaur; Raja Fayad
Journal:  Biochim Biophys Acta       Date:  2011-12-16

Review 8.  Adiponectin, driver or passenger on the road to insulin sensitivity?

Authors:  Risheng Ye; Philipp E Scherer
Journal:  Mol Metab       Date:  2013-04-19       Impact factor: 7.422

9.  Visfatin induces oxidative stress in differentiated C2C12 myotubes in an Akt- and MAPK-independent, NFkB-dependent manner.

Authors:  Radu C Oita; Dudley Ferdinando; Steve Wilson; Christopher Bunce; Dawn J Mazzatti
Journal:  Pflugers Arch       Date:  2009-11-08       Impact factor: 3.657

10.  Chemerin is a novel adipocyte-derived factor inducing insulin resistance in primary human skeletal muscle cells.

Authors:  Henrike Sell; Jurga Laurencikiene; Annika Taube; Kristin Eckardt; Andrea Cramer; Angelika Horrighs; Peter Arner; Jürgen Eckel
Journal:  Diabetes       Date:  2009-08-31       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.